Tetraphase Pharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$1.4M
Doctors Paid
1,915
Transactions
4,801
2023 Total
$11,613
Payment Breakdown by Category
Research$583,133 (42.0%)
Consulting$179,603 (12.9%)
Food & Beverage$113,602 (8.2%)
Travel$81,518 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $583,133 | 199 | 42.0% |
| Honoraria | $415,542 | 162 | 29.9% |
| Consulting Fee | $179,603 | 21 | 12.9% |
| Food and Beverage | $113,602 | 4,099 | 8.2% |
| Travel and Lodging | $81,518 | 143 | 5.9% |
| Education | $15,250 | 13 | 1.1% |
| Gift | $950.12 | 164 | 0.1% |
Payments by Type
General
$806,464
4,602 transactions
Research
$583,133
199 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Safety and PK Study of IV Eravacycline | $398,777 | 0 | 152 |
| In vitro Activity of Eravacycline against Recent Bacterial Isolates Recovered from Patients with Cancer | $71,122 | 0 | 3 |
| Assessment of the Physical Compatibility of Eravacycline with Select Intravenous Drugs During Simulated Y-site Administration | $43,160 | 0 | 2 |
| In vitro susceptibility of Eravacycline against multi-drug resistant enterococci and enterobacteriaceae | $35,860 | 0 | 3 |
| Clinical Observation Outcomes Data with Eravacycline (CODE) | $18,713 | 0 | 36 |
| In vitro Activity of Eravacycline against staphlococcal biofilms from prosthetic joint infection | $12,501 | 0 | 2 |
| In Vitro activity of Eravacycline against Clinical Strains from Brooklyn, NY Hospitals | $3,000 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Marya Zilberberg, M.d, M.D | Pulmonary Disease | Leeds, MA | $98,500 | $0 |
| Abhay Dhand, M.d, M.D | Infectious Disease | Valhalla, NY | $60,295 | $0 |
| Dr. Michael Gelfand, Md, MD | Infectious Disease | Memphis, TN | $46,435 | $0 |
| Andrew Shorr, Md, MD | Pulmonary Disease | Washington, DC | $41,283 | $0 |
| Unknown Provider | — | — | $32,030 | $0 |
| Mr. Tony Hodges, M.d, M.D | Pulmonary Disease | Phoenix, AZ | $27,046 | $0 |
| Dr. Edward Dominguez, M.d, M.D | Infectious Disease | Dallas, TX | $26,500 | $0 |
| Jason Sniffen, Do, DO | Infectious Disease | Altamonte Springs, FL | $25,741 | $0 |
| Dr. Joshua Rosenberg, M.d, M.D | Critical Care Medicine | Brooklyn, NY | $22,963 | $0 |
| Dr. Arthur Jeng, M.d, M.D | Infectious Disease | Sylmar, CA | $22,513 | $0 |
| Markian Bochan, Md, MD | Infectious Disease | Carmel, IN | $19,069 | $0 |
| Dr. Juan Diaz, D.o, D.O | Infectious Disease | Altamonte Springs, FL | $17,777 | $0 |
| Guillermo Padilla, M.d, M.D | Infectious Disease | Shreveport, LA | $15,734 | $0 |
| Dr. John Mazuski, Md, MD | Surgical Critical Care | Saint Louis, MO | $12,603 | $0 |
| Dr. Teena Chopra, Md, MD | Internal Medicine | Detroit, MI | $12,167 | $0 |
| Christopher Cooper, Md, MD | Infectious Disease | Altamonte Springs, FL | $11,961 | $0 |
| Dr. Marin Kollef, Md, MD | Pulmonary Disease | Saint Louis, MO | $11,866 | $0 |
| Dr. Alexander Evens, D.o, D.O | Infectious Disease | Turlock, CA | $11,385 | $0 |
| Bruce Friedman, M.d, M.D | Critical Care Medicine | Augusta, GA | $11,215 | $0 |
| Dr. Andrew Dold, D.o, D.O | Infectious Disease | Dacula, GA | $9,706 | $0 |
| Dr. Brent Laartz, Md, MD | Infectious Disease | New Port Richey, FL | $9,390 | $0 |
| Patrick Lee, M.d, M.D | Surgery | Springfield, MA | $8,580 | $0 |
| Dr. Ali Hassoun, Md, MD | Infectious Disease | Huntsville, AL | $8,506 | $0 |
| Dr. David Evans, M.d, M.D | Surgical Critical Care | Columbus, OH | $8,452 | $0 |
| Ramesh Nathan, Md, MD | Infectious Disease | Thousand Oaks, CA | $7,979 | $0 |
About Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. has made $1.4M in payments to 1,915 healthcare providers, recorded across 4,801 transactions in the CMS Open Payments database. In 2023, the company paid $11,613. The top product by payment volume is Xerava ($928,388).
Payments were distributed across 78 medical specialties. The top specialty by payment amount is Infectious Disease ($384,360 to 626 doctors).
Payment categories include: Food & Beverage ($113,602), Consulting ($179,603), Research ($583,133), Travel & Lodging ($81,518).
Tetraphase Pharmaceuticals, Inc. is associated with 1 products in the CMS Open Payments database.